
US Market Entry
A US entry plan built on evidence, not optimism.
For European B2B companies with proven home-market revenue and a board asking what America actually costs.
What we establish first
Whether the US opportunity is real at your stage, or a year too early
The narrowest wedge that can produce reference customers
How positioning and pricing must change for the US buyer
Which route to market (direct, channel, or hybrid) fits your economics
What you leave with
A 90-day recommendation with sequencing and cost
A localized offer and message tested against the target ICP
A pipeline design and partner map
A commercial operating plan your team can run
Playbook
US Market Entry Playbook for Nordic SMEs
An 11-page CEO guide to choosing your first US market, validating demand and deciding what to fund next, with a readiness scorecard and a one-page decision brief.
New: Nordic House Florida
A shared US showroom and office for Nordic companies.
A fully managed building in Boca Raton, Florida: your branded showroom bay, a private office and a team to host your buyers. Now taking members, move-in from January 2027.
Two ways to start
Diagnose first. Then launch.
- Shortest estimate
- Upper end of the range
About 2 weeks
US Entry Diagnostic
A 90-day recommendation you can take to the board.
6 to 8 weeks
US Launch Sprint
A localized offer, pipeline design and partner map your team can run.
Timings are indicative. Scope, weekly commitment, fee and duration are agreed together before an assignment begins.
Get in touchWhen it fits
Find the first buying situation. Not the whole of America.
For international B2B technology companies with evidence of demand at home and a specific question about the US opportunity.
Read more
Greatweek helps narrow a large market to a credible first customer segment, adapt the commercial offer and decide what to fund next. The existing international playbook remains a useful starting point, not a substitute for testing your own business case.
What the work puts in your hands
A focused US customer profile and target-account priorities, including the buying group and trigger to act.
Positioning and pricing hypotheses that reflect the US buyer’s alternatives and approval process.
A first-market plan covering direct sales, partners, qualification and the first commercial hire.
A decision brief separating evidence, unresolved assumptions and the next investment gate.
The engagement
Scope the work. Execute. Review the evidence.

Step 1 of 3
Diagnose readiness
Review home-market proof, product dependencies, customer economics and leadership capacity. Establish what must be true for US expansion to make sense.
Before we start
Is this only for Nordic companies?
No. The service supports international B2B technology companies considering US launch or growth. Our playbook is written for Nordic SMEs, while each commercial mandate is tailored to the company and its market.
Diagnostic or launch sprint: which should we start with?
A diagnostic fits when market selection, readiness or route to market is still unresolved. A launch sprint fits when the first segment and offer are sufficiently clear to begin focused execution. We agree the starting point before work begins.
Will the work guarantee our first customers?
No. The mandate is designed to develop and test commercial opportunities, not guarantee sales. Buyer access, evaluation criteria, procurement and product readiness all affect the result.

Make the next US decision with better evidence.
Tell us what needs to change, where the business stands today and what decision comes next. We will discuss whether a defined Greatweek engagement is the right next step.